# Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1

> **NCT01851135** · NA · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 286 (actual)

## Conditions studied

- Neurofibromatosis Type 1

## Interventions

- **OTHER:** Neuropsychological examination and quality of life measures

## Key facts

- **NCT ID:** NCT01851135
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851135, "Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01851135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*